AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira sales drop.

JPMorgan’s net income soared 50% to more than $14 billion in the fourth quarter as the bank’s profit and revenue easily beat ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

It's not just JPMorgan Chase. Across the industry, banks are rethinking their remote-work policies — but experts say it won't ...

In a report released today, Glenn Schorr from Evercore ISI maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report), with a ...

JPMorgan Chase's reported on Wednesday a more than 50% jump in net income for the fourth quarter, primarily helped by growth in revenue. The US financial services firm's earnings, as well as revenue, ...

In a report released today, John McDonald CFA from Truist Financial assigned a Hold rating to JPMorgan Chase & Co. (JPM – Research Report).

Illumina will offer its DRAGEN analysis software on Nvidia’s accelerated computing platforms through the next-gen sequencing ...

Databricks, a tech giant with two Romanians among its founders, secured USD 5 billion in funding from creditors such as Blackstone, Apollo Global Management Inc., and Blue Owl Capital Inc., marking ...